|
Volumn 25, Issue 2, 2009, Pages 385-393
|
Utilization and dosage pattern of echinocandins for treatment of fungal infections in US hospital practice
|
Author keywords
Anidulafungin; Antifungal; Caspofungin; Echinocandin; Micafungin
|
Indexed keywords
ANIDULAFUNGIN;
ANTIFUNGAL AGENT;
CASPOFUNGIN;
CORTICOSTEROID;
IMMUNOSUPPRESSIVE AGENT;
MICAFUNGIN;
ECHINOCANDIN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
ARTICLE;
ASPERGILLOSIS;
BONE MARROW TRANSPLANTATION;
CANCER INCIDENCE;
CANDIDIASIS;
CENTRAL VENOUS CATHETERIZATION;
CHEMOPROPHYLAXIS;
CLINICAL PRACTICE;
COHORT ANALYSIS;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DATA BASE;
DRUG UTILIZATION;
FEMALE;
FOOD AND DRUG ADMINISTRATION;
HEMODIALYSIS;
HOSPITAL CARE;
HOSPITALIZATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION PREVENTION;
INFECTION RISK;
LENGTH OF STAY;
LOADING DRUG DOSE;
MAINTENANCE DRUG DOSE;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD REVIEW;
MORTALITY;
MYCOSIS;
NEUTROPENIA;
OBSERVATIONAL STUDY;
ORGAN TRANSPLANTATION;
RECOMMENDED DRUG DOSE;
RETROSPECTIVE STUDY;
TREATMENT DURATION;
TREATMENT INDICATION;
TREATMENT OUTCOME;
UNITED STATES;
AGED;
DOSE RESPONSE;
DRUG USE;
HOSPITAL;
MIDDLE AGED;
AGED;
ANTIFUNGAL AGENTS;
COHORT STUDIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG UTILIZATION REVIEW;
ECHINOCANDINS;
FEMALE;
HOSPITALS;
HUMANS;
MALE;
MIDDLE AGED;
MYCOSES;
RETROSPECTIVE STUDIES;
UNITED STATES;
|
EID: 64249160242
PISSN: 03007995
EISSN: 14734877
Source Type: Journal
DOI: 10.1185/03007990802619599 Document Type: Article |
Times cited : (15)
|
References (12)
|